Philadelphia, Pennsylvania 19104

  • Related Disorders


The purpose of this study is to evaluate the behavioral and physiological effects of buprenorphine and naloxone, both alone and in combination.


Please contact site for information.



Primary Contact:

Principal Investigator
Charles O'Brien, M.D., Ph.D.
PDVAMC Treatment Research Center

Backup Contact:


Location Contact:

Philadelphia, Pennsylvania 19104
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: June 17, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.